12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Comera Life Sciences (CMRA), SenesTech (SNES), Aravive (ARAV), China SXT Pharmaceuticals (SXTC), Co-Diagnostics (CODX), and Oncternal Therapeutics (ONCT) saw gains following their Q3 earnings reports. Conversely, XTL Biopharmaceuticals (XTLB), NeuroMetrix (NURO), TRACON Pharma (TCON), Jaguar Health (JAGX), Intelligent Bio Solutions (INBS), and Sunshine Biopharma (SBFM) experienced declines. The movements were attributed to recent earnings reports and trading volumes.
November 10, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aravive stock increased by 9.44% to $0.14, with a trading volume of 68.8K shares.
Aravive's stock price rise is likely due to the after-market trading activity, potentially in response to recent company developments or market sentiment.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Comera Life Sciences stock increased by 11.6% to $0.28 after Q3 earnings report.
The positive movement in CMRA's stock price is likely due to the recent Q3 earnings report, which may have exceeded investor expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Co-Diagnostics stock rose 7.89% to $1.23 after the release of their Q3 earnings report.
The positive movement in CODX's stock price is likely a result of the Q3 earnings report, which may have met or surpassed market expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Oncternal Therapeutics shares increased by 7.82% to $0.31, coinciding with their Q3 earnings release.
ONCT's stock price appreciation is likely connected to the Q3 earnings announcement, suggesting a positive investor response.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
SenesTech stock rose 9.51% to $0.26 following the Q3 earnings announcement.
The increase in SNES's stock price can be attributed to the Q3 earnings release, which may have been positively received by the market.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
China SXT Pharmaceuticals saw an 8.67% increase to $2.13 in its stock price.
The gain in SXTC's stock price may be influenced by market dynamics and investor reactions to recent company news or sector trends.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Intelligent Bio Solutions stock fell 7.43% to $0.53, with a significant increase in trading volume.
The decline in INBS's stock price, along with a surge in trading volume, suggests a negative market response, potentially due to the Q1 earnings report released two days ago.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Jaguar Health shares declined by 7.95% to $0.27, with trading volume at 146.7K shares.
Jaguar Health's stock price drop could be influenced by market trends or investor reactions to recent company developments.
CONFIDENCE 75
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
NeuroMetrix shares dropped by 11.01% to $0.44 with a high trading volume.
NeuroMetrix's stock price decline, accompanied by a high trading volume, suggests a strong market reaction, possibly to recent earnings or other significant news.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Sunshine Biopharma stock fell 5.61% to $0.27, with a market cap of $7.0 million.
The decrease in SBFM's stock price may be a reaction to broader market sentiment or specific to the company's performance.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
TRACON Pharma's stock declined by 10.82% to $0.21 after their Q3 earnings report.
The decrease in TCON's stock price is likely a direct response to the Q3 earnings report, which may have not met investor expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
XTL Biopharmaceuticals shares fell by 14.1% to $0.79 in the after-market session.
The decline in XTLB's stock price may be due to negative investor sentiment or disappointing company news.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80